StonvexLoading…
StonvexStonvexStonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $55.52 | $54.74 | -1.40% | 1.8M |
| 05-12 | $53.65 | $55.22 | +2.93% | 1.2M |
| 05-13 | $55.41 | $54.06 | -2.44% | 1.6M |
| 05-14 | $54.39 | $53.88 | -0.94% | 2.1M |
| 05-15 | $53.91 | $54.50 | +1.09% | 1.1M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $182.31M | $587.86M | $417.13M | $262.92M |
Operating Income | $32.07M | $-546.37M | $-573.63M | $-567.53M |
Net Income | $35.13M | $-528.26M | $-560.36M | $-575.65M |
EPS (Diluted) | $0.41 | $-7.77 | $-9.88 | $-15.05 |
Total Assets | $728.77M | $744.76M | $769.80M | $693.65M |
Total Liabilities | $417.21M | $366.23M | $361.93M | $320.00M |
Cash & Equivalents | $186.67M | $208.00M | $261.34M | $237.17M |
Free Cash Flow OCF − CapEx | $43.00M | $170.73M | $107.25M | $24.90M |
Shares Outstanding | 82.39M | 0 | 0 | 0 |
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.